Bai X, Zhu J, Chen Y, Sun H. The design and development of LRRK2 inhibitors as novel therapeutics for Parkinson's disease. Future Med Chem. 2025 Jan;17(2):221-236. Epub 2024 Dec 24 PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.